Cabozantinib for untreated advanced renal cell carcinoma

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 19.33 MB)

  Published:

  03 October 2018

• Final appraisal determination committee papers (PDF 2.2 MB)

  Published:

  03 October 2018